Cite
HARVARD Citation
Augustin, M. et al. (2023). Patient-reported well-being in value-based care using tildrakizumab in a real-world setting: protocol of a multinational, phase IV, 1-cohort prospective observational study (the POSITIVE study). BMJ open. 13 (2), p. . [Online].